For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Medigene, Inc.

USPTO Granted Patents = 10

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 124

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Ian Richard Matthews (3 out of 9 patents)

Bent Karsten Jakobsen (2 out of 32 patents)

Meir Glick (2 out of 5 patents)

4. Dong Qiang (2 out of 2 patents)

5. Brian Horsburgh (2 out of 2 patents)

6. Francis Tufaro (2 out of 3 patents)

7. Paul Johnson (1 out of 5 patents)

8. Samuel D Rabkin (1 out of 16 patents)

9. Tomoki Todo (1 out of 6 patents)

10. Robert L Martuza (1 out of 22 patents)

11. Ian Richard Mathews (1 out of 1 patent)

12. Jeffery Ostrove (1 out of 1 patent)

13. Hyeon Soo Kim (1 out of 4 patents)

14. Ji Hyung Chung (1 out of 3 patents)

15. Jeffrey Ostrove (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12263206 - Pharmaceutical composition for preventing or treating obesity or sarcopenia, containing IF1 as active ingredient (2025-04-01),

2. 7816361 - Immuno inhibitory pyrazolone compounds (2010-10-19),

3. 7749745 - Viral vectors and their use in therapeutic methods (2010-07-06),

4. 7598247 - Immunomodulating heterocyclic compounds (2009-10-06),

5. 7566713 - Immuno inhibitory heterocyclic compounds (2009-07-28),

6. 7425339 - CD8alpha mutants (2008-09-16),

7. 7329731 - Soluble T cell receptor (2008-02-12),

8. 7276505 - Immunomodulating heterocyclic compounds (2007-10-02),

9. 6642207 - Artificial chromosome constructs containing foreign nucleic acid sequences (2003-11-04),

10. 6277621 - Artificial chromosome constructs containing foreign nucleic acid sequences (2001-08-21),

Medigene, Inc. is a biotechnology company focused on the development of cutting-edge immunotherapies for the treatment of various types of cancer. With a team of skilled scientists and researchers, Medigene is dedicated to advancing the field of personalized medicine through the use of innovative technologies and targeted therapies. The company's pipeline includes a range of novel immunotherapeutic approaches designed to harness the power of the immune system to fight cancer. Medigene is committed to making a meaningful impact on the lives of patients through the development of effective and safe treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

10 Patents

#504 in San Diego, CA

#6,877 in California

#28,938 in US

#54,238 in the World

San Diego, CA, United States of America

Medigene, Inc.

Forward Citations = 124

16 inventors:

Ian Richard Matthews (3 out of 9 patents)

Bent Karsten Jakobsen (2 out of 32 patents)

Meir Glick (2 out of 5 patents)

4. Dong Qiang (2 out of 2 patents)

5. Brian Horsburgh (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…